Abstract:Plakophilin (PKP1) 1 is a member of the arm-repeat family of catenins and acts as a structural component of desmosomes, which are important stabilizers of cell-cell adhesion. Besides this, PKP1 also occurs in a non-junctional, cytoplasmic form contributing to post-transcriptional regulation of gene expression. Moreover, PKP1 is expressed in the prostate epithelium but its expression is frequently downregulated in prostate cancers with a more aggressive phenotype. This observation may imply a tumour-suppressive role of PKP1. We found that, in prostatic adenocarcinomas with PKP1 deficiency, the occurrence of T-cells, B-cells, macrophages and neutrophils were significantly increased. In a PKP1-deficient prostatic cancer cell line expressing IL8, these levels were statistically meaningfully reduced upon PKP1 re-expression. When analysing prostatic PKP1 knockdown cell lines, the mRNA and protein levels of additional cytokines, namely CXCL1 and IL6, were upregulated. The effect was rescued upon re-expression of a PKP1 RNAi-resistant form. The corresponding mRNAs were co-precipitated with cytoplasmic PKP1, indicating that they are components of PKP1-containing mRNA ribonucleoprotein particles. Moreover, the mRNA half-lives of CXCL1, IL8 and IL6 were significantly increased in PKP1-deficient cells, showing that these mRNAs were stabilized by PKP1. In an in vitro migration assay, the higher cytokine concentrations led to higher migration rates of THP1 and PBMC cells. This finding implies that PKP1 loss of expression in vivo correlates with the recruitment of immune cells into the tumour area to set up a tumour-specific environment. One may speculate that this newly established tumour environment has tumour-suppressive characteristics and thereby accelerates tumour progression and metastasis.

Role and function of plakophilin 3 in cancer progression and skin disease

Plakophilin 1 in carcinogenesis

Analysis of Multiple Human Tumor Cases Reveals the Carcinogenic Effects of PKP3

Defining desmosomal plakophilin-3 interactions

Cytoplasmic Skp2 Expression Is Increased In Human Melanoma And Correlated With Patient Survival

Role of REIC/Dkk-3 Protein in Tumorigenesis

The PI3K/Akt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders

PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer

The oncogenic role of protein kinase D3 in cancer

Phospholipase D as a key modulator of cancer progression

Loss of Periplakin Expression is Associated with the Tumorigenesis of Colorectal Carcinoma

Plakophilin 1 deficiency in prostatic tumours is correlated with immune cell recruitment and controls the up-regulation of cytokine expression post-transcriptionally

Oncogenic Functions of Protein Kinase D2 and D3 in Regulating Multiple Cancer-Related Pathways in Breast Cancer

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling

Paraneoplastic Pemphigus Autoantibodies Against C-terminus of Desmoplakin Induced Acantholysis In Vitro and In Vivo

Inhibition of Spindle and Kinetochore Associated Complex Subunit 3 Suppresses the Proliferation and Invasion and Induced the Apoptosis of Cutaneous Melanoma by Affecting the PI3K/Akt Pathway

Carcinogenic Roles of the Protein Kinase Plk1

SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients

The function of human epidermal growth factor receptor-3 and its role in tumors (Review).

Novel homozygous deletion of the plakophilin-1 gene in a Chinese patient with ectodermal dysplasia-skin fragility syndrome